101. Semi-Synthesis and In Vitro Anti-Cancer Evaluation of Magnolol Derivatives
- Author
-
Hong-Mei Li, Chang-Hao Zhang, Hui Ma, Xiaolong Sun, Cheng-Zhu Wu, Meilin Zhu, Yiqun Dai, and Bohan Li
- Subjects
Pharmaceutical Science ,Organic chemistry ,Antineoplastic Agents ,Triple Negative Breast Neoplasms ,migration ,semi-synthesis ,Lignans ,Article ,Analytical Chemistry ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,QD241-441 ,Cell Movement ,Cell Line, Tumor ,Drug Discovery ,medicine ,Cytotoxic T cell ,Humans ,Neoplasm Invasiveness ,Physical and Theoretical Chemistry ,Cytotoxicity ,030304 developmental biology ,Cell Proliferation ,0303 health sciences ,Chemistry ,Biphenyl Compounds ,Cancer ,medicine.disease ,invasion ,magnolol ,In vitro ,Magnolol ,Blot ,Biochemistry ,nervous system ,Chemistry (miscellaneous) ,Cell culture ,030220 oncology & carcinogenesis ,Benzyl group ,Molecular Medicine ,cytotoxicity ,Female ,Drug Screening Assays, Antitumor - Abstract
Magnolol (MAG), a biphenolic neolignan, has various biological activities including antitumor effects. In this study, 15 MAG derivatives were semi-synthesized and evaluated for their in vitro anticancer activities. From these derivatives, compound 6a exhibited the best cytotoxic activity against four human cancer cell lines, with IC50 values ranging from 20.43 to 28.27 μM. Wound-healing and transwell assays showed that compound 6a significantly inhibited the migration and invasion of MDA-MB-231 cells. In addition, Western blotting experiments, performed using various concentrations of 6a, demonstrated that it downregulates the expression of HIF-1α, MMP-2, and MMP-9 in a concentration-dependent manner. Overall, these results suggest that substituting a benzyl group having F atoms substituted at the C2 position on MAG is a viable strategy for the structural optimization of MAG derivatives as anticancer agents.
- Published
- 2021